CRON vs CURLF vs VRNO Stock Comparison

Cronos, Curaleaf Holdings and Verano Holdings Prices as of Nov 13, 2026 Peers: Industry group
CRON Cronos Group Inc.
$3.38 +7.0% 1M +36.3% 1Y
Market cap
$1.21B
P/E
20.9x
Revenue (TTM)
$271.85M
Div. yield
–
Cannabis Consumer Staples
7 wins
VRNO Verano Holdings Corp.
$4.21 -19.3% 1M -28.6% 1Y
Market cap
$289.56M
P/E
–
Revenue (TTM)
$845.15M
Div. yield
–
Cannabis Consumer Staples
1 win

Head to Head

10 decided of 12

Cronos leads on 7 of the 12 questions below (Cronos 7, Curaleaf Holdings 2, Verano Holdings 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCRONCURLFVRNOLeader
Larger companyMarket capitalisation $1.21B $2.14B $289.56M CURLF
Cheaper on earningsLower P/E, profitable companies only 20.9x -209.2x -1.3x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 19.9x 98.1x — CRON
Faster revenue growthRevenue growth, trailing twelve months +54.3% +7.3% +1.4% CRON
More profitableNet margin, trailing twelve months 21.3% -0.8% -25.9% CRON
Better return on capitalReturn on invested capital — 0.7% -12.2% CURLF
Less leveragedLower net debt / EBITDA — 2.6x -24.6x VRNO
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +36.3% +1.4% -28.6% CRON
Better 5-year returnAnnualised price return, 5 years -11.6%/yr -24.3%/yr -42.9%/yr CRON
Less volatileAnnualised volatility, 1 year 40.0% 100.1% 119.1% CRON
Higher overall scoreMean of the five percentile scores vs peers 88/100 59/100 46/100 CRON

Percentile Scorecard

CRONCURLFVRNO

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCRONCURLFVRNO
Valuation 68 #13 of 39 45 #22 of 39 21 #31 of 39
Growth 97 #2 of 37 83 #7 of 37 22 #29 of 37
Profitability 81 #8 of 37 67 #13 of 37 42 #22 of 37
Financial Health 100 #1 of 41 43 #24 of 41 65 #15 of 41
Shareholder Returns 94 #2 of 17 56 #8 of 17 81 #4 of 17
Overall 88 59 46
  • CRON ranked among 41 companies in Tobacco and Cannabis
  • CURLF ranked among 41 companies in Tobacco and Cannabis
  • VRNO ranked among 41 companies in Tobacco and Cannabis

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCRONCURLFVRNOSPY
1 month +7.0%-8.0%-19.3% -2.0%
3 months +7.6%-17.2%-30.0% -2.8%
6 months +28.5%-23.3%-20.6% +2.0%
Year to date +28.5%+3.8%-33.2% +10.6%
1 year +36.3%+1.4%-28.6% +12.2%
3 years +69.0%-19.5%-81.1% +68.1%
3 years, per year +19.1%-7.0%-42.7% +18.9%
5 years -46.0%-75.2%-93.9% +61.4%
5 years, per year -11.6%-24.3%-42.9% +10.1%

Risk

MeasureCRONCURLFVRNOSPY
Volatility, 1Y 40.0%100.1%119.1% 13.6%
Downside volatility, 1Y 36.1%96.4%112.9% 13.9%
Beta vs S&P 500, 1Y 0.351.150.85 1.00
Return / volatility, 1Y 0.910.01-0.24 0.90
Max drawdown, 5Y -72.7%-92.7%-96.4% -25.4%
From 52-week high -9.1%-44.3%-51.6% -3.2%
52-week high $3.72$14.10$8.70 $779.14
52-week low $2.30$5.67$3.95 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCRONCURLFVRNO
P/E now vs peer median 21.5xmedian 18.9x -203.2xmedian 18.9x -1.4xmedian 18.9x
P/S now vs peer median 4.6xmedian 0.7x 1.5xmedian 0.7x 2.2xmedian 0.7x
EV/EBITDA now vs peer median 22.2xmedian 11.5x 12.6xmedian 11.5x -181.0xmedian 11.5x
P/FCF now vs peer median 19.0xmedian 14.4x 43.0xmedian 14.4x 29.3xmedian 14.4x
P/B now vs peer median 1.1xmedian 0.9x 2.5xmedian 0.9x 2.7xmedian 0.9x
PEG now vs peer median 0.59median 1.00 -3.30median 1.00 0.02median 1.00

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCRONCURLFVRNO
Revenue $271.85M $1.35B $845.15M
Gross profit $96.08M $659.48M $404.41M
Operating income $7.10M $10.83M -$129.43M
Net income $67.38M -$10.23M -$218.71M
Free cash flow $65.38M $48.38M $62.34M
R&D $5.35M – –
EPS (diluted) $0.16 $-0.04 $-2.99
Cash & equivalents $411.19M $92.39M $102.05M
Total debt – $629.48M $390.18M
Shares (diluted) 370.72M 264.88M 73.12M
Enterprise value -$1.98B $1.76B -$54.44M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCRONCURLFVRNO
P/E 21.5x -203.2x -1.4x
P/FCF 19.0x 43.0x 29.3x
P/Operating cash flow 15.3x 18.1x 16.4x
P/S 4.6x 1.5x 2.2x
P/B 1.1x 2.5x 2.7x
P/Tangible book 1.1x -22.2x 13.5x
EV/EBITDA 22.2x 12.6x -181.0x
EV/EBIT 70.6x 241.6x -16.3x
EV/Revenue 1.8x 1.9x 2.5x
EV/FCF 7.7x 54.1x 33.9x
EV/Operating cash flow 6.2x 22.8x 18.9x
PEG (3Y EPS CAGR) 0.59 -3.30 0.02

Growth

14 metrics
MetricCRONCURLFVRNO
Revenue growth (1Y) 54.3% 7.3% 1.4%
Revenue CAGR (3Y) 33.1% 0.1% -3.0%
Gross profit growth (1Y) 67.4% 5.0% -2.6%
Gross profit CAGR (3Y) 104.4% 4.7% -4.3%
Operating income growth (1Y) 133.4% -39.1% 48.9%
Operating income CAGR (3Y) 27.6% 48.7% -8.1%
Net income growth (1Y) 58.3% 95.8% 37.0%
Net income CAGR (3Y) 37.9% 71.9% 5.1%
EPS growth (1Y) 66.4% 96.1% -211.7%
EPS CAGR (3Y) 36.6% 61.7% -58.9%
Operating cash flow growth (1Y) 272.8% -30.4% 35.3%
Operating cash flow CAGR (3Y) 43.7% 6.6% 1.6%
Free cash flow growth (1Y) 1,317% 221.7% 70.8%
Free cash flow CAGR (3Y) 40.3% 35.9% -4.0%

Profitability

14 metrics
MetricCRONCURLFVRNO
Gross margin 35.3% 48.8% 47.9%
EBITDA margin 8.3% 15.4% -1.4%
Operating margin 2.6% 0.8% -15.3%
Pretax margin 22.1% -7.6% -22.0%
Net margin 21.3% -0.8% -25.9%
FCF margin 24.0% 3.6% 7.4%
Operating cash flow margin 29.8% 8.5% 13.2%
Return on equity 6.1% -0.9% -32.5%
Return on assets 5.8% -0.3% -12.8%
Return on invested capital – 0.7% -12.2%
Return on capital employed 0.6% 0.4% -8.1%
Asset turnover 0.2x 0.5x 0.5x
Cash conversion (OCF / net income) 1.2x -11.2x -0.5x
Stock comp / revenue 2.4% 3.4% 1.3%

Financial Health

11 metrics
MetricCRONCURLFVRNO
Debt / assets – 22.5% 22.9%
Debt / equity – 0.7x 0.6x
Net debt / EBITDA – 2.6x -24.6x
Debt / FCF – 13.0x 6.3x
Liabilities / assets 6.1% 69.7% 60.6%
Equity / assets 93.9% 30.3% 39.4%
Interest coverage – – –
Current ratio 12.7x 1.6x 3.6x
Quick ratio 11.6x 0.6x 1.1x
Cash ratio 11.0x 0.3x 0.9x
Altman Z-score 11.79 0.44 0.63

Shareholder Returns

7 metrics
MetricCRONCURLFVRNO
Dividend yield – – –
Net buyback yield 3.7% -0.1% 0.2%
Shareholder yield 3.7% -0.1% 0.2%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCRONCURLFVRNO
Forward P/E 19.9xFY2026 98.1xFY2026 –
EPS, next fiscal year $0.17FY2026 $0.08FY2026 $-0.42FY2026
EPS growth, the year after +11.8% -412.5% –
Revenue, next fiscal year $218.83MFY2026 $1.41BFY2026 $800.50MFY2026
Revenue growth, next FY +49.3%FY2026 +10.9%FY2026 -2.6%FY2026
Revenue growth, the year after +22.5% -0.1% +9.2%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCRONCURLFVRNO
Held by institutions 12.8% 0.0% 0.2%
Institutions holding 197 2 1
Change in shares held, QoQ -2.5% -86.3% –
Institutions buying 71 1 0
Institutions selling 41 1 1
Buyers to sellers 1.73 1.00 0.00

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CRONCURLFVRNO
CRON 1.00 0.51 0.47
CURLF 0.51 1.00 0.79
VRNO 0.47 0.79 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, CRON, CURLF and VRNO?

Curaleaf Holdings (CURLF) is the largest by market capitalisation: Cronos (CRON) $1.21B, Curaleaf Holdings (CURLF) $2.14B, Verano Holdings (VRNO) $289.56M.

Which company is growing faster?

Cronos (CRON) grew revenue fastest over the trailing twelve months: Cronos (CRON) +54.3%, Curaleaf Holdings (CURLF) +7.3%, Verano Holdings (VRNO) +1.4%.

Which company is more profitable?

Cronos (CRON) has the highest net margin (Cronos (CRON) 21.3%, Curaleaf Holdings (CURLF) -0.8%, Verano Holdings (VRNO) -25.9%). On return on invested capital, Curaleaf Holdings (CURLF) leads (Curaleaf Holdings (CURLF) 0.7%, Verano Holdings (VRNO) -12.2%).

Which stock has performed better?

Over the past year Cronos (CRON) returned the most: Cronos (CRON) +36.3%, Curaleaf Holdings (CURLF) +1.4%, Verano Holdings (VRNO) -28.6%. Over five years, Cronos (CRON) compounded fastest (Cronos (CRON) -11.6%/yr, Curaleaf Holdings (CURLF) -24.3%/yr, Verano Holdings (VRNO) -42.9%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Cronos (CRON) has been the steadiest (Cronos (CRON) 40.0%, Curaleaf Holdings (CURLF) 100.1%, Verano Holdings (VRNO) 119.1%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, CRON, CURLF and VRNO?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Cronos (CRON) leads on 7. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.